Correspondence

On behalf of the leading national transplant organizations, we write to you as original sponsors of the “Dialysis PATIENTS Demonstration Act of 2017” (H.R. 4143) to express our significant concerns about the potential impact of this legislation on Medicare beneficiaries’ continued access to kidney transplantation.

October 20, 2017 Representative John R. Carter U.S. House of Representatives 2110 Rayburn House Office Building Washington D.C. 20015 Re:

October 16, 2017 Linda L. Porter, PhD Pain Policy Advisor, Office of Pain Policy Office of the Director National Institute of Neurological Disorders and Stroke 31 Center Drive, Room 8A31 Bethesda, MD 20892 Dear Dr. Porter: As undersigned members of the Protecting Access to Pain Relief (PAPR)

           October 16, 2017 Acting Secretary U.S. Department of Health and Human Services Washington, D.C.

October 7, 2017 Dear Chairmen Brady and Walden and Ranking Members Neal and Pallone: On behalf of the undersigned organizations, we are writing to you to urge you to consider enacting legislation that would require the Centers for Medicare and Medicaid Services (CMS)

The Honorable U.S. House of Representatives Washington, DC 20515 Dear Rep. :

The Honorable Jason Smith U.S. House of Representatives 1118 Longworth House Office Bldg Washington, DC 20515 The Honorable Earl Blumenauer U.S. House of Representatives 1111 Longworth House Office Bldg Washington, DC 20515 RE: Dialysis Patients Demonstration Act of 2016 (H.R. 5942)

Dear Senators Alexander, Murray, Collins and Shaheen, Thank you for consideration of the National Clinical Care Commission Act by the Health, Education, Labor, and Pensions Committee on April 26, 2017.